ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 986,44
0,36%
Dow Jones
38 675,68
1,18%
DAX
18 091,88
0,55%
Brent Oil
83,43
0,37%
Bitcoin
65 267,00
1,98%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Protara Therapeutics Inc (TARA)

  7. Protara Therapeutics Inc (TARA) Actualités

TARA Protara Therapeutics Inc

2,91
0,00 (0,00%)
Avant marché
Dernière mise à jour : 10:16:50
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Protara Therapeutics Inc TARA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 2,91 10:16:50
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,91
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202414:00GLOBEProtara Therapeutics Announces First Quarter 2024 Financial..
05/4/202414:04GLOBEProtara Therapeutics Announces Oversubscribed $45 Million..
05/4/202414:02GLOBEProtara Therapeutics Announces Alignment with FDA on..
05/4/202414:00GLOBEProtara Therapeutics Announces Positive Three-Month Data..
13/3/202413:00GLOBEProtara Therapeutics Announces Fourth Quarter and Full Year..
28/2/202414:00GLOBEProtara Therapeutics to Present at the TD Cowen 44th Annual..
23/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202314:30GLOBEProtara Therapeutics Announces Presentation of Additional..
15/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
03/11/202313:31EDGAR2Form S-3 - Registration statement under Securities Act of..
03/11/202313:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202313:10EDGAR2Form 8-K - Current report
03/11/202313:00GLOBEProtara Therapeutics Announces Third Quarter 2023 Financial..
23/10/202314:00GLOBEProtara Therapeutics Announces Dosing of First Patient in..
20/9/202314:30GLOBEProtara Therapeutics Announces Dosing of First Patient in..
05/9/202313:30GLOBEProtara Therapeutics to Present at the H.C. Wainwright 25th..
03/8/202314:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202314:12EDGAR2Form 8-K - Current report
03/8/202314:00GLOBEProtara Therapeutics Announces Second Quarter 2023 Financial..
18/7/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202314:00GLOBEProtara Therapeutics Announces Dosing of First Patients in..

Dernières Valeurs Consultées

NASDAQ
TARA
Protara Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés